HEADER TRANSFERASE 09-MAY-18 5ZV2 TITLE FGFR-1 IN COMPLEX WITH LIGAND LENVATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: FGFR-1,BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1,BFGF-R-1, COMPND 6 FMS-LIKE TYROSINE KINASE 2,FLT-2,N-SAM,PROTO-ONCOGENE C-FGR; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FGF RECEPTOR KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX, KEYWDS 2 BIOSYNTHETIC PROTEIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.MATSUKI,T.HOSHI,Y.YAMAMOTO,M.IKEMORI-KAWADA,Y.MINOSHIMA, AUTHOR 2 Y.FUNAHASHI,J.MATSUI REVDAT 3 16-OCT-24 5ZV2 1 REMARK REVDAT 2 22-NOV-23 5ZV2 1 REMARK REVDAT 1 11-JUL-18 5ZV2 0 JRNL AUTH M.MATSUKI,T.HOSHI,Y.YAMAMOTO,M.IKEMORI-KAWADA,Y.MINOSHIMA, JRNL AUTH 2 Y.FUNAHASHI,J.MATSUI JRNL TITL LENVATINIB INHIBITS ANGIOGENESIS AND TUMOR FIBROBLAST GROWTH JRNL TITL 2 FACTOR SIGNALING PATHWAYS IN HUMAN HEPATOCELLULAR CARCINOMA JRNL TITL 3 MODELS. JRNL REF CANCER MED V. 7 2641 2018 JRNL REFN ISSN 2045-7634 JRNL PMID 29733511 JRNL DOI 10.1002/CAM4.1517 REMARK 2 REMARK 2 RESOLUTION. 2.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 100.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 16880 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.900 REMARK 3 FREE R VALUE TEST SET COUNT : 692 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.86 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.93 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1184 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.63 REMARK 3 BIN R VALUE (WORKING SET) : 0.3960 REMARK 3 BIN FREE R VALUE SET COUNT : 40 REMARK 3 BIN FREE R VALUE : 0.3950 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4526 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 8 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 84.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.46000 REMARK 3 B22 (A**2) : 9.28000 REMARK 3 B33 (A**2) : -2.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.70000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.401 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.373 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 20.525 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.915 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4522 ; 0.008 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4291 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6137 ; 1.232 ; 1.989 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9816 ; 1.980 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 559 ; 5.369 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 189 ;33.971 ;23.915 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 751 ;13.625 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ; 9.573 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 682 ; 0.059 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5084 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 990 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2257 ;10.251 ;11.410 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2256 ;10.233 ;11.408 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2809 ;14.586 ;19.189 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2810 ;14.587 ;19.194 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2264 ;11.191 ;12.100 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2265 ;11.189 ;12.101 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3323 ;15.884 ;20.040 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4950 ;18.529 ;50.377 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4951 ;18.527 ;50.379 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 463 762 B 463 762 15290 0.13 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5ZV2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1300007377. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17573 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.860 REMARK 200 RESOLUTION RANGE LOW (A) : 100.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.8700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 4UWY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17.70 % PEG-5000-MME, 0.20 M REMARK 280 (NH4)2SO4, 0.10 M TRIS PH 7.00, CRYO 25% ETHYLENGLYCOLE IN REMARK 280 RESERVOIR SOLUTION., VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 105.10700 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.73200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 105.10700 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.73200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 PRO A 579 REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 CYS A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 GLU A 592 REMARK 465 ILE A 648 REMARK 465 HIS A 649 REMARK 465 ASN A 763 REMARK 465 GLN A 764 REMARK 465 PRO B 579 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 CYS B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 ALA B 645 REMARK 465 ARG B 646 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 465 THR B 658 REMARK 465 ASN B 659 REMARK 465 GLY B 660 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 464 CG CD OE1 OE2 REMARK 480 LYS A 502 CE NZ REMARK 480 LYS A 504 CD CE NZ REMARK 480 LYS A 517 CD CE NZ REMARK 480 SER A 518 OG REMARK 480 GLU A 522 CD OE1 OE2 REMARK 480 LYS A 523 CG CD CE NZ REMARK 480 SER A 526 OG REMARK 480 SER A 530 OG REMARK 480 LYS A 540 NZ REMARK 480 LYS A 542 NZ REMARK 480 ARG A 627 CD NE CZ NH1 NH2 REMARK 480 LEU A 644 CG CD1 CD2 REMARK 480 ASP A 647 CG OD1 OD2 REMARK 480 ILE A 651 CD1 REMARK 480 LYS A 655 CD CE NZ REMARK 480 LYS A 656 CD CE NZ REMARK 480 THR A 658 OG1 CG2 REMARK 480 GLU A 707 CG CD OE1 OE2 REMARK 480 LYS A 711 CG CD CE NZ REMARK 480 LYS A 714 CE NZ REMARK 480 MET A 731 SD CE REMARK 480 LYS B 482 CD CE NZ REMARK 480 GLU B 486 CG CD OE1 OE2 REMARK 480 ILE B 498 CD1 REMARK 480 ASP B 501 CG OD1 OD2 REMARK 480 LYS B 502 CG CD CE NZ REMARK 480 ASP B 503 CG OD1 OD2 REMARK 480 LYS B 504 CG CD CE NZ REMARK 480 ARG B 507 CG CD NE CZ NH1 NH2 REMARK 480 LYS B 510 CD CE NZ REMARK 480 LYS B 517 NZ REMARK 480 GLU B 522 CD OE1 OE2 REMARK 480 LYS B 523 NZ REMARK 480 MET B 537 SD CE REMARK 480 LYS B 540 CE NZ REMARK 480 LYS B 542 CE NZ REMARK 480 LYS B 566 NZ REMARK 480 GLU B 592 CG CD OE1 OE2 REMARK 480 LEU B 595 CD1 CD2 REMARK 480 SER B 597 OG REMARK 480 LYS B 598 CG CD CE NZ REMARK 480 LEU B 644 CD1 CD2 REMARK 480 TYR B 653 CG CD1 CD2 CE1 CE2 CZ OH REMARK 480 LYS B 655 CG CD CE NZ REMARK 480 LYS B 656 CG CD CE NZ REMARK 480 PHE B 673 CG CD1 CD2 CE1 CE2 CZ REMARK 480 ARG B 675 CG CD NE CZ NH1 NH2 REMARK 480 ILE B 676 CD1 REMARK 480 LYS B 711 CD CE NZ REMARK 480 LYS B 714 CE NZ REMARK 480 LYS B 721 NZ REMARK 480 ASN B 724 CG OD1 ND2 REMARK 480 GLU B 728 CD OE1 OE2 REMARK 480 LYS B 748 NZ REMARK 480 LEU B 760 CD1 CD2 REMARK 480 ASN B 763 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 643 N - CA - C ANGL. DEV. = -17.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 491 73.62 64.42 REMARK 500 ARG A 622 -9.59 81.07 REMARK 500 ASP A 623 48.23 -159.83 REMARK 500 LEU A 644 77.73 52.77 REMARK 500 ARG A 646 157.57 174.00 REMARK 500 TRP A 737 31.93 -89.87 REMARK 500 LEU A 760 71.36 -105.28 REMARK 500 GLU B 486 75.29 -159.56 REMARK 500 ARG B 576 40.27 -106.42 REMARK 500 LYS B 617 30.70 -99.60 REMARK 500 ARG B 622 -9.94 80.59 REMARK 500 ASP B 623 48.57 -158.60 REMARK 500 ASP B 641 17.33 59.16 REMARK 500 TRP B 737 32.48 -89.84 REMARK 500 ASN B 763 2.74 83.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LEV A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LEV B 801 DBREF 5ZV2 A 461 764 UNP P11362 FGFR1_HUMAN 461 764 DBREF 5ZV2 B 461 764 UNP P11362 FGFR1_HUMAN 461 764 SEQADV 5ZV2 SER A 460 UNP P11362 EXPRESSION TAG SEQADV 5ZV2 ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 5ZV2 SER B 460 UNP P11362 EXPRESSION TAG SEQADV 5ZV2 ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQRES 1 A 305 SER SER GLU TYR GLU LEU PRO GLU ASP PRO ARG TRP GLU SEQRES 2 A 305 LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS PRO LEU GLY SEQRES 3 A 305 GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA GLU ALA ILE SEQRES 4 A 305 GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL THR LYS VAL SEQRES 5 A 305 ALA VAL LYS MET LEU LYS SER ASP ALA THR GLU LYS ASP SEQRES 6 A 305 LEU SER ASP LEU ILE SER GLU MET GLU MET MET LYS MET SEQRES 7 A 305 ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU LEU GLY ALA SEQRES 8 A 305 CYS THR GLN ASP GLY PRO LEU TYR VAL ILE VAL GLU TYR SEQRES 9 A 305 ALA SER LYS GLY ASN LEU ARG GLU TYR LEU GLN ALA ARG SEQRES 10 A 305 ARG PRO PRO GLY LEU GLU TYR CYS TYR ASN PRO SER HIS SEQRES 11 A 305 ASN PRO GLU GLU GLN LEU SER SER LYS ASP LEU VAL SER SEQRES 12 A 305 CYS ALA TYR GLN VAL ALA ARG GLY MET GLU TYR LEU ALA SEQRES 13 A 305 SER LYS LYS CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 14 A 305 VAL LEU VAL THR GLU ASP ASN VAL MET LYS ILE ALA ASP SEQRES 15 A 305 PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE ASP TYR TYR SEQRES 16 A 305 LYS LYS THR THR ASN GLY ARG LEU PRO VAL LYS TRP MET SEQRES 17 A 305 ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR THR HIS GLN SEQRES 18 A 305 SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE SEQRES 19 A 305 PHE THR LEU GLY GLY SER PRO TYR PRO GLY VAL PRO VAL SEQRES 20 A 305 GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY HIS ARG MET SEQRES 21 A 305 ASP LYS PRO SER ASN CYS THR ASN GLU LEU TYR MET MET SEQRES 22 A 305 MET ARG ASP CYS TRP HIS ALA VAL PRO SER GLN ARG PRO SEQRES 23 A 305 THR PHE LYS GLN LEU VAL GLU ASP LEU ASP ARG ILE VAL SEQRES 24 A 305 ALA LEU THR SER ASN GLN SEQRES 1 B 305 SER SER GLU TYR GLU LEU PRO GLU ASP PRO ARG TRP GLU SEQRES 2 B 305 LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS PRO LEU GLY SEQRES 3 B 305 GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA GLU ALA ILE SEQRES 4 B 305 GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL THR LYS VAL SEQRES 5 B 305 ALA VAL LYS MET LEU LYS SER ASP ALA THR GLU LYS ASP SEQRES 6 B 305 LEU SER ASP LEU ILE SER GLU MET GLU MET MET LYS MET SEQRES 7 B 305 ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU LEU GLY ALA SEQRES 8 B 305 CYS THR GLN ASP GLY PRO LEU TYR VAL ILE VAL GLU TYR SEQRES 9 B 305 ALA SER LYS GLY ASN LEU ARG GLU TYR LEU GLN ALA ARG SEQRES 10 B 305 ARG PRO PRO GLY LEU GLU TYR CYS TYR ASN PRO SER HIS SEQRES 11 B 305 ASN PRO GLU GLU GLN LEU SER SER LYS ASP LEU VAL SER SEQRES 12 B 305 CYS ALA TYR GLN VAL ALA ARG GLY MET GLU TYR LEU ALA SEQRES 13 B 305 SER LYS LYS CYS ILE HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 14 B 305 VAL LEU VAL THR GLU ASP ASN VAL MET LYS ILE ALA ASP SEQRES 15 B 305 PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE ASP TYR TYR SEQRES 16 B 305 LYS LYS THR THR ASN GLY ARG LEU PRO VAL LYS TRP MET SEQRES 17 B 305 ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR THR HIS GLN SEQRES 18 B 305 SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE SEQRES 19 B 305 PHE THR LEU GLY GLY SER PRO TYR PRO GLY VAL PRO VAL SEQRES 20 B 305 GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY HIS ARG MET SEQRES 21 B 305 ASP LYS PRO SER ASN CYS THR ASN GLU LEU TYR MET MET SEQRES 22 B 305 MET ARG ASP CYS TRP HIS ALA VAL PRO SER GLN ARG PRO SEQRES 23 B 305 THR PHE LYS GLN LEU VAL GLU ASP LEU ASP ARG ILE VAL SEQRES 24 B 305 ALA LEU THR SER ASN GLN HET LEV A 801 30 HET LEV B 801 30 HETNAM LEV 4-{3-CHLORO-4-[(CYCLOPROPYLCARBAMOYL)AMINO]PHENOXY}-7- HETNAM 2 LEV METHOXYQUINOLINE-6-CARBOXAMIDE HETSYN LEV LENVATINIB FORMUL 3 LEV 2(C21 H19 CL N4 O4) FORMUL 5 HOH *8(H2 O) HELIX 1 AA1 PRO A 474 ASP A 476 5 3 HELIX 2 AA2 GLY A 485 ALA A 488 5 4 HELIX 3 AA3 THR A 521 GLY A 539 1 19 HELIX 4 AA4 ASN A 568 ARG A 576 1 9 HELIX 5 AA5 SER A 596 LYS A 617 1 22 HELIX 6 AA6 ALA A 625 ARG A 627 5 3 HELIX 7 AA7 LEU A 662 MET A 667 5 6 HELIX 8 AA8 ALA A 668 ARG A 675 1 8 HELIX 9 AA9 THR A 678 THR A 695 1 18 HELIX 10 AB1 PRO A 705 GLU A 715 1 11 HELIX 11 AB2 THR A 726 TRP A 737 1 12 HELIX 12 AB3 VAL A 740 ARG A 744 5 5 HELIX 13 AB4 THR A 746 LEU A 760 1 15 HELIX 14 AB5 PRO B 474 ASP B 476 5 3 HELIX 15 AB6 THR B 521 GLY B 539 1 19 HELIX 16 AB7 ASN B 568 ARG B 576 1 9 HELIX 17 AB8 SER B 596 LYS B 617 1 22 HELIX 18 AB9 ALA B 625 ARG B 627 5 3 HELIX 19 AC1 LEU B 662 MET B 667 5 6 HELIX 20 AC2 ALA B 668 ARG B 675 1 8 HELIX 21 AC3 THR B 678 THR B 695 1 18 HELIX 22 AC4 PRO B 705 GLU B 715 1 11 HELIX 23 AC5 THR B 726 TRP B 737 1 12 HELIX 24 AC6 VAL B 740 ARG B 744 5 5 HELIX 25 AC7 THR B 746 SER B 762 1 17 SHEET 1 AA1 5 LEU A 478 LEU A 484 0 SHEET 2 AA1 5 VAL A 492 ILE A 498 -1 O LEU A 494 N LYS A 482 SHEET 3 AA1 5 VAL A 508 MET A 515 -1 O THR A 509 N ALA A 497 SHEET 4 AA1 5 TYR A 558 GLU A 562 -1 O VAL A 561 N ALA A 512 SHEET 5 AA1 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 AA2 2 VAL A 629 VAL A 631 0 SHEET 2 AA2 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 AA3 5 LEU B 478 PRO B 483 0 SHEET 2 AA3 5 GLN B 491 ILE B 498 -1 O LEU B 494 N LYS B 482 SHEET 3 AA3 5 VAL B 508 MET B 515 -1 O THR B 509 N ALA B 497 SHEET 4 AA3 5 TYR B 558 GLU B 562 -1 O VAL B 561 N ALA B 512 SHEET 5 AA3 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 AA4 2 VAL B 629 VAL B 631 0 SHEET 2 AA4 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 LINK OE1 GLU A 464 CZ ARG B 507 1555 2566 1.43 SITE 1 AC1 12 GLY A 485 PHE A 489 ALA A 512 LYS A 514 SITE 2 AC1 12 GLU A 531 MET A 535 GLU A 562 ALA A 564 SITE 3 AC1 12 GLY A 567 LEU A 630 ASP A 641 PHE A 642 SITE 1 AC2 15 LEU B 484 GLY B 485 PHE B 489 ALA B 512 SITE 2 AC2 15 LYS B 514 GLU B 531 MET B 535 VAL B 561 SITE 3 AC2 15 GLU B 562 TYR B 563 ALA B 564 GLY B 567 SITE 4 AC2 15 LEU B 630 ASP B 641 PHE B 642 CRYST1 210.214 57.464 65.955 90.00 106.75 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004757 0.000000 0.001432 0.00000 SCALE2 0.000000 0.017402 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015834 0.00000